Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline + Sitagliptin in Type 2 Diabetes Mellitus
NCT06329882Phase 2Completed
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in type 2 diabetes mellitus (T2DM). Started Mar 2024; status: completed.
02
Drugs
doxycycline
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06329882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329882.